Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Titel:
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Auteur:
Bourlière, Marc Bronowicki, Jean-Pierre de Ledinghen, Victor Hézode, Christophe Zoulim, Fabien Mathurin, Philippe Tran, Albert Larrey, Dominique G Ratziu, Vlad Alric, Laurent Hyland, Robert H Jiang, Deyuan Doehle, Brian Pang, Phillip S Symonds, William T Subramanian, G Mani McHutchison, John G Marcellin, Patrick Habersetzer, François Guyader, Dominique Grangé, Jean-Didier Loustaud-Ratti, Véronique Serfaty, Lawrence Metivier, Sophie Leroy, Vincent Abergel, Armand Pol, Stanislas